How U.S. Reimbursement Impacts MedTech Product Design

Published on: 01/09/2025

Design decisions can make or break reimbursement success. Learn why U.S. payment systems should influence your MedTech product development strategy.

U.S. reimbursement strategyMedTech product developmentmedical device codingCPT code planningMedTech coding and payment
How U.S. Reimbursement Impacts MedTech Product Design

How U.S. Payers View “Value” — And Why “Cost-Saving” and “Costs More” Don’t Always Mix

Published on: 18/08/2025

U.S. payers don’t define “value” the same way as clinicians or investors. This article breaks down how payers assess value — and how early-stage MedTech startups can build compelling strategies for reimbursement success.

US ReimbursementMedtech ReimbursementUS Payers
How U.S. Payers View “Value” — And Why “Cost-Saving” and “Costs More” Don’t Always Mix

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

Published on: 06/02/2025

Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.

first-mover advantage in reimbursementreimbursement strategy for medical devicespayer evidence requirementsMedTech reimbursement challengescomparative coverage thresholdsclinical trial evidenceCMS policyhealthcare payerscoverage approvalmarket accesscoding and paymentreal-world evidencemedical device innovationwhy it’s harder for new MedTech companies to get coveragehow to compete with an already reimbursed medical device
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

Published on: 20/08/2024

FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.

FDAPayer ExpectationsMedicarePayment ReadinessCommercial
The World After FDA Clearance: From HOORAY! To WAIT, WHAT?